Qiming U.S. Ventures Management as of June 30, 2025
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tourmaline Bio (TRML) | 50.2 | $12M | 742k | 15.99 | |
| Jasper Therapeutics Com New (JSPR) | 21.8 | $5.2M | 929k | 5.55 | |
| Korro Bio (KRRO) | 19.5 | $4.6M | 368k | 12.49 | |
| Ventyx Biosciences (VTYX) | 3.7 | $882k | 412k | 2.14 | |
| Hillevax | 3.1 | $742k | 373k | 1.99 | |
| Kezar Life Sciences Com New (KZR) | 1.6 | $380k | 83k | 4.58 |
